He works on the molecular mechanisms of kidney injury and repair. Specifically, the research of the Anders group focuses the mechanisms kidney necroinflammation in ischemic, embolic, and toxic forms of acute kidney injury. Another focus is kidney remodelling in chronic kidney disease. The Anders group identifies and validates potential treatment targets including. Preclinical drug testing is explored also in public-private partnerships.